BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Chen X. p53 tumor suppressor and iron homeostasis. FEBS J 2019;286:620-9. [PMID: 30133149 DOI: 10.1111/febs.14638] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Sfera A, Osorio C, Maguire G, Rahman L, Afzaal J, Cummings M, Maldonado JC. COVID-19, ferrosenescence and neurodegeneration, a mini-review. Prog Neuropsychopharmacol Biol Psychiatry 2021;109:110230. [PMID: 33373681 DOI: 10.1016/j.pnpbp.2020.110230] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Azemin WA, Alias N, Ali AM, Shamsir MS. Structural and functional characterisation of HepTH1-5 peptide as a potential hepcidin replacement. J Biomol Struct Dyn 2021;:1-24. [PMID: 34870559 DOI: 10.1080/07391102.2021.2011415] [Reference Citation Analysis]
3 Benzel J, Fendrich V. Familial Pancreatic Cancer. Oncol Res Treat. 2018;41:611-618. [PMID: 30269130 DOI: 10.1159/000493473] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
4 Recalcati S, Correnti M, Gammella E, Raggi C, Invernizzi P, Cairo G. Iron Metabolism in Liver Cancer Stem Cells. Front Oncol 2019;9:149. [PMID: 30941302 DOI: 10.3389/fonc.2019.00149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Li-Ou Z, Hong-Zan S, Xiao-Xi B, Zhong-Wei C, Zai-Ming L, Jun X, Qi-Yong G. Correlation between tumor glucose metabolism and multiparametric functional MRI (IVIM and R2*) metrics in cervical carcinoma: Evidence from integrated 18 F-FDG PET/MR. J Magn Reson Imaging 2019;49:1704-12. [PMID: 30390401 DOI: 10.1002/jmri.26557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Lacroix M, Riscal R, Arena G, Linares LK, Le Cam L. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer. Mol Metab 2020;33:2-22. [PMID: 31685430 DOI: 10.1016/j.molmet.2019.10.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
7 Tsamouri MM, Steele TM, Mudryj M, Kent MS, Ghosh PM. Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans. Biomedicines 2021;9:1472. [PMID: 34680588 DOI: 10.3390/biomedicines9101472] [Reference Citation Analysis]
8 Lahalle A, Lacroix M, De Blasio C, Cissé MY, Linares LK, Le Cam L. The p53 Pathway and Metabolism: The Tree That Hides the Forest. Cancers (Basel) 2021;13:E133. [PMID: 33406607 DOI: 10.3390/cancers13010133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Petronek MS, Spitz DR, Buettner GR, Allen BG. Linking Cancer Metabolic Dysfunction and Genetic Instability through the Lens of Iron Metabolism. Cancers (Basel) 2019;11:E1077. [PMID: 31366108 DOI: 10.3390/cancers11081077] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
10 Xie Y, Tan Y, Yang C, Zhang X, Xu C, Qiao X, Xu J, Tian S, Fang C, Kang C. Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis. Cancer Biol Med 2019;16:784-96. [PMID: 31908895 DOI: 10.20892/j.issn.2095-3941.2019.0143] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
11 Wang H, Li B, Asha K, Pangilinan RL, Thuraisamy A, Chopra H, Rokudai S, Yu Y, Prives CL, Zhu Y. The ion channel TRPM7 regulates zinc-depletion-induced MDMX degradation. J Biol Chem 2021;297:101292. [PMID: 34627839 DOI: 10.1016/j.jbc.2021.101292] [Reference Citation Analysis]
12 Zeng L, Zhou J, Wang X, Zhang Y, Wang M, Su P. Cadmium attenuates testosterone synthesis by promoting ferroptosis and blocking autophagosome-lysosome fusion. Free Radic Biol Med 2021;176:176-88. [PMID: 34610361 DOI: 10.1016/j.freeradbiomed.2021.09.028] [Reference Citation Analysis]
13 Azemin WA, Alias N, Ali AM, Shamsir MS. In silico analysis prediction of HepTH1-5 as a potential therapeutic agent by targeting tumour suppressor protein networks. J Biomol Struct Dyn 2021;:1-27. [PMID: 34935583 DOI: 10.1080/07391102.2021.2017349] [Reference Citation Analysis]
14 Park JM, Mau CZ, Chen YC, Su YH, Chen HA, Huang SY, Chang JS, Chiu CF. A case-control study in Taiwanese cohort and meta-analysis of serum ferritin in pancreatic cancer. Sci Rep 2021;11:21242. [PMID: 34711879 DOI: 10.1038/s41598-021-00650-7] [Reference Citation Analysis]
15 Nie Y, Yun X, Zhang Y, Wang X. Targeting metabolic reprogramming in chronic lymphocytic leukemia. Exp Hematol Oncol 2022;11:39. [PMID: 35761419 DOI: 10.1186/s40164-022-00292-z] [Reference Citation Analysis]
16 Zhang Y, Feng X, Zhang J, Chen X. Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression. Mol Cancer Res 2020;18:1039-49. [PMID: 32276991 DOI: 10.1158/1541-7786.MCR-19-1104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, Jiang F, Peng ZY. Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis. Oxid Med Cell Longev 2019;2019:5080843. [PMID: 31737171 DOI: 10.1155/2019/5080843] [Cited by in Crossref: 109] [Cited by in F6Publishing: 129] [Article Influence: 36.3] [Reference Citation Analysis]
18 Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol 2021:S1044-579X(21)00060-2. [PMID: 33785447 DOI: 10.1016/j.semcancer.2021.03.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
19 Gamage SMK, Lee KTW, Dissabandara DLO, Lam AK, Gopalan V. Dual role of heme iron in cancer; promotor of carcinogenesis and an inducer of tumour suppression. Exp Mol Pathol 2021;120:104642. [PMID: 33905708 DOI: 10.1016/j.yexmp.2021.104642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Ali A, Shafarin J, Unnikannan H, Al-Jabi N, Jabal RA, Bajbouj K, Muhammad JS, Hamad M. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer. Int J Biol Sci 2021;17:4474-92. [PMID: 34803511 DOI: 10.7150/ijbs.62236] [Reference Citation Analysis]
21 Yokus O, Herek C, Cinli TA, Goze H, Serin I. Iron overload during the treatment of acute leukemia: pretransplant transfusion experience. Int J Hematol Oncol 2021;10:IJH36. [PMID: 34840721 DOI: 10.2217/ijh-2021-0005] [Reference Citation Analysis]
22 Zhang J, Kong X, Zhang Y, Sun W, Wang J, Chen M, Chen X. FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression. J Pathol 2020;251:284-96. [PMID: 32304229 DOI: 10.1002/path.5451] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Huang Y, Wu B, Shen D, Chen J, Yu Z, Chen C. Ferroptosis in a sarcopenia model of senescence accelerated mouse prone 8 (SAMP8). Int J Biol Sci 2021;17:151-62. [PMID: 33390840 DOI: 10.7150/ijbs.53126] [Reference Citation Analysis]
24 Shibabaw T, Teferi B, Molla MD, Ayelign B. Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer. Breast Cancer (Dove Med Press) 2020;12:165-80. [PMID: 33116818 DOI: 10.2147/BCTT.S276404] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Wojtusik J, Curry E, Roth TL. Rhinoceros Serum microRNAs: Identification, Characterization, and Evaluation of Potential Iron Overload Biomarkers. Front Vet Sci 2021;8:711576. [PMID: 34977204 DOI: 10.3389/fvets.2021.711576] [Reference Citation Analysis]